Literature DB >> 25733581

CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells.

Patricia Amé-Thomas1, Sylvia Hoeller2, Catherine Artchounin3, Jan Misiak4, Mounia Sabrina Braza4, Rachel Jean1, Jérôme Le Priol4, Céline Monvoisin4, Nadine Martin5, Philippe Gaulard3, Karin Tarte1.   

Abstract

In follicular lymphoma (FL), follicular helper T cells (TFH) have been depicted as one of the main components of the malignant B-cell niche and a promising therapeutic target. Although defined by their capacity to sustain FL B-cell growth together with specific gene expression and cytokine secretion profiles, FL-TFH constitute a heterogeneous cell population. However, specific markers reflecting such functional heterogeneity are still lacking. In this study, we demonstrate that CD10 identifies a subset of fully functional germinal center TFH in normal secondary lymphoid organs. Importantly, this subset is amplified in the FL context, unlike in other B-cell lymphomas with a follicular growth pattern. Furthermore, whereas FL-TFH produce high levels of interleukin (IL)-21 and low levels of IL-17 irrespectively of their CD10 expression, CD10(pos) FL-TFH specifically exhibit an IL-4(hi)IFN-γ(lo)TNF-α(hi) cytokine profile associated with a high capacity to sustain directly and indirectly malignant B-cell survival. Altogether, our results highlight the important role of this novel functional subset in the FL cell niche.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25733581      PMCID: PMC4401349          DOI: 10.1182/blood-2015-02-625152

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.

Authors:  P Amé-Thomas; J Le Priol; H Yssel; G Caron; C Pangault; R Jean; N Martin; T Marafioti; P Gaulard; T Lamy; T Fest; G Semana; K Tarte
Journal:  Leukemia       Date:  2011-10-21       Impact factor: 11.528

3.  Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes.

Authors:  Fabien Guilloton; Gersende Caron; Cédric Ménard; Céline Pangault; Patricia Amé-Thomas; Joëlle Dulong; John De Vos; Delphine Rossille; Catherine Henry; Thierry Lamy; Olivier Fouquet; Thierry Fest; Karin Tarte
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

4.  Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.

Authors:  Jason R Westin; Fuliang Chu; Min Zhang; Luis E Fayad; Larry W Kwak; Nathan Fowler; Jorge Romaguera; Fredrick Hagemeister; Michelle Fanale; Felipe Samaniego; Lei Feng; Veerabhadran Baladandayuthapani; Zhiqiang Wang; Wencai Ma; Yanli Gao; Michael Wallace; Luis M Vence; Laszlo Radvanyi; Tariq Muzzafar; Rinat Rotem-Yehudar; R Eric Davis; Sattva S Neelapu
Journal:  Lancet Oncol       Date:  2013-12-11       Impact factor: 41.316

5.  High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.

Authors:  June H Myklebust; Jonathan M Irish; Joshua Brody; Debra K Czerwinski; Roch Houot; Holbrook E Kohrt; John Timmerman; Jonathan Said; Michael R Green; Jan Delabie; Arne Kolstad; Ash A Alizadeh; Ronald Levy
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

6.  Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling.

Authors:  G Epron; P Ame-Thomas; J Le Priol; C Pangault; J Dulong; T Lamy; T Fest; K Tarte
Journal:  Leukemia       Date:  2011-07-26       Impact factor: 11.528

7.  Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.

Authors:  Shahryar Kiaii; Andrew J Clear; Alan G Ramsay; Derek Davies; Ajanthah Sangaralingam; Abigail Lee; Maria Calaminici; Donna S Neuberg; John G Gribben
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

8.  Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.

Authors:  Seema Rawal; Fuliang Chu; Min Zhang; Hyun Jun Park; Durga Nattamai; Shibichakravarthy Kannan; Rakesh Sharma; David Delgado; Tina Chou; Heather Y Lin; Veerabhadran Baladandayuthapani; Amber Luong; Francisco Vega; Nathan Fowler; Chen Dong; R Eric Davis; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

Review 9.  The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.

Authors:  Patricia Amé-Thomas; Karin Tarte
Journal:  Semin Cancer Biol       Date:  2013-08-23       Impact factor: 15.707

10.  Neuropilin-1 expression characterizes T follicular helper (Tfh) cells activated during B cell differentiation in human secondary lymphoid organs.

Authors:  Amédée Renand; Pierre Milpied; Julien Rossignol; Julie Bruneau; François Lemonnier; Michael Dussiot; Séverine Coulon; Olivier Hermine
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

View more
  26 in total

1.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

2.  Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology.

Authors:  Sanam Loghavi; Sa A Wang; L Jeffrey Medeiros; Jeffrey L Jorgensen; Xin Li; Zijun Y Xu-Monette; Roberto N Miranda; Ken H Young
Journal:  Leuk Lymphoma       Date:  2016-04-22

3.  Antigen-presenting cell-derived IL-6 restricts the expression of GATA3 and IL-4 by follicular helper T cells.

Authors:  Mélanie Hercor; Maelle Anciaux; Sébastien Denanglaire; Delphine Debuisson; Oberdan Leo; Fabienne Andris
Journal:  J Leukoc Biol       Date:  2016-07-29       Impact factor: 4.962

4.  Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop.

Authors:  Roch Houot; Philippe Gaulard; Robert Schreiber; Ira Mellman; Olivier Lambotte; Pierre G Coulie; Thierry Fest; Alan Korman; Ronald Levy; Margaret Shipp; Karin Tarte; Holbrook Kohrt; Aurélien Marabelle; Stephen Ansell; Hervé Watier; Andrea van Elsas; Arun Balakumaran; Frederick Arce Vargas; Sergio A Quezada; Gilles Salles; Daniel Olive
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

Review 5.  Role of the microenvironment across histological subtypes of NHL.

Authors:  Karin Tarte
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 6.  Prognostic factors in follicular lymphoma: new tools to personalize risk.

Authors:  Carla Casulo
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

7.  T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.

Authors:  Sarah E Josefsson; Kanutte Huse; Arne Kolstad; Klaus Beiske; Daniela Pende; Chloé B Steen; Else Marit Inderberg; Ole Christian Lingjærde; Bjørn Østenstad; Erlend B Smeland; Ronald Levy; Jonathan M Irish; June H Myklebust
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

Review 8.  Unmet needs in the first-line treatment of follicular lymphoma.

Authors:  C Casulo; L Nastoupil; N H Fowler; J W Friedberg; C R Flowers
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

9.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

10.  CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas.

Authors:  Kieu-Suong Le; Patricia Amé-Thomas; Karin Tarte; Françoise Gondois-Rey; Samuel Granjeaud; Florence Orlanducci; Etienne D Foucher; Florence Broussais; Reda Bouabdallah; Thierry Fest; Dominique Leroux; Sapna Yadavilli; Patrick A Mayes; Luc Xerri; Daniel Olive
Journal:  Blood Adv       Date:  2018-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.